Biohaven Ltd. Common Shares is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapies for neurological diseases and rare disorders. Its innovative pipeline includes treatments for migraines, Alzheimer’s disease, and spinocerebellar ataxia. With a strong commitment to research and development, Biohaven aims to bring new hope to patients in need.
- Latest
- Trending
